Skip to main content
NIH funding notice RFA-DA-17-010

Improved Technologies and Ligands for Non-invasive Brain Imaging (R41/R42)

Closed on August 17, 2016.

Posted
April 12, 2016
Close date
August 17, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $450,184 in first-year total cost, median $225,092.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 GXM-A (14)]2

Most frequent institutions

  1. HIGHLIGHTI, INC1
  2. THERANANO, LLC1
Competing awards under RFA-DA-17-010 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Quantitative Non-Invasive Brain Imaging using Magnetic Nanoparticles1R41DA043974-01SRIDHAR, SRINIVASTHERANANO, LLC, MA$225,211ZDA1
2017Advancing a novel portable detection method for cannabis intoxication1R42DA043977-01EVINS, A EDENMARAVIC, MELISSA CULHANEHIGHLIGHTI, INC, MA$224,973ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DA-17-010: Improved Technologies and Ligands for Non-invasive Brain Imaging (R41/R42) | ScienceDex | ConductScience